WO2004024169A1 - Composition comprising an abrasive agent for treating insect bites - Google Patents

Composition comprising an abrasive agent for treating insect bites Download PDF

Info

Publication number
WO2004024169A1
WO2004024169A1 PCT/US2002/030244 US0230244W WO2004024169A1 WO 2004024169 A1 WO2004024169 A1 WO 2004024169A1 US 0230244 W US0230244 W US 0230244W WO 2004024169 A1 WO2004024169 A1 WO 2004024169A1
Authority
WO
WIPO (PCT)
Prior art keywords
pharmaceutical composition
composition
topical application
application according
itch
Prior art date
Application number
PCT/US2002/030244
Other languages
French (fr)
Inventor
Patrick Kennedy
Original Assignee
Patrick Kennedy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Patrick Kennedy filed Critical Patrick Kennedy
Priority to AU2002332213A priority Critical patent/AU2002332213A1/en
Priority to PCT/US2002/030244 priority patent/WO2004024169A1/en
Publication of WO2004024169A1 publication Critical patent/WO2004024169A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/612—Crustaceans, e.g. crabs, lobsters, shrimps, krill or crayfish; Barnacles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/52—Juglandaceae (Walnut family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/534—Mentha (mint)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4873—Cysteine endopeptidases (3.4.22), e.g. stem bromelain, papain, ficin, cathepsin H
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Definitions

  • the present invention relates to non-prescription topical compositions and, more specifically, to a composition including an abrasive for treating effects such as itching, pain, and swelling resulting from insect bites and stings.
  • the present invention relates to non-prescription topical compositions and, more specifically, to a composition including an abrasive for treating effects such as itching, pain, and swelling resulting from insect bites and stings.
  • a still further object of the present invention is to provide a composition that is able to alleviate the discomfort associated with an insect bite or sting that is economical in cost to manufacture.
  • the instant invention includes the provision of a topical skin preparation adapted to relieve the discomfort associated with insect bites comprising an effective amount of an abrasive ingredient (e.g. walnut shells), and an itch reducing ingredient (e.g. papain).
  • an abrasive ingredient e.g. walnut shells
  • an itch reducing ingredient e.g. papain
  • the present invention is directed to a method and pharmaceutical composition for reducing the itching associated with insect bites and stings.
  • the method comprises applying a therapeutically effective amount of an abrasive ingredient and an itch reducing ingredient in a suitable pharmaceutical carrier to the surface of the skin proximate to the bite.
  • the preferred abrasive ingredient is walnut shells and the preferred itch reducing ingredient is papain.
  • any known abrasive and itch reducing ingredients may be used in the composition of the present invention.
  • the pharmaceutical carrier may be water based.
  • a method of relieving the allergenic effects of insect stings and bites comprises topically rubbing a pharmaceutical composition containing, among other materials, an abrasive ingredient, such as walnut shells (35-60 mesh) on the affected area.
  • a pharmaceutical composition for topical use in accordance with the method comprises an active abrasive ingredient, as indicated above, in a carrier suitable for topical application to the human skin, for example, in a mixture of propylene glycol and water.
  • the topical pharmaceutical carrier may include any substance capable of dispersing and maintaining contact between the active abrasive and anti-itch ingredients and the skin.
  • the vehicle may be glycerin, alcohol or water based. Examples of such vehicles include aloe vera, which is a gel base, together with ethanol, isopropyl alcohol, water, and propylene glycol. Other water-based alcohol/glycerin vehicles and carriers are within the scope of the present invention.
  • a pharmaceutical composition containing an abrasive ingredient works very well to alleviate the allergenic effects of insect stings and bites.
  • walnut shells 35-60 mesh
  • other similarly sized abrasive materials can be used in the overall pharmaceutical composition including but not limited to any of the following: pumice, plastic materials, sand or stone, glass, seed or fruit shells, seeds, metal, any sort of brush, abrasive applicators, chitosan or ground crab shells.
  • the remainder of the pharmaceutical composition may comprise carriers, emulsifiers, and/or dispersants and may take the form of a powder, liquid, or paste.
  • the final pharmaceutical composition is preferably made in the form of a cream or lotion so that it can be rubbed directly on the skin at the affected site.
  • the instant cream or lotion is rubbed on the bite or sting affected area, it appears that the active abrasive ingredients actually draw the allergenic or poisonous substance from the affected area along with any body materials resulting from swelling or infection.
  • a mild anesthetic such as menthol, chloroform, benzocaine or an antibiotic may be added to the overall claimed abrasive pharmaceutical composition in a manner well known in the art.
  • a pharmaceutical composition for relieving the itch, pain, and swelling resulting from insect bites and stings, and methods for producing and using the composition is disclosed by the present invention.
  • the method preferably comprises topically applying to the affected area the composition containing an abrasive ingredient and an anti-itch enzyme, both of which are dispersed in a carrier containing effective amounts of emulsifiers, and/or dispersants and may take the form of a powder, liquid, or paste.
  • the final pharmaceutical composition is preferably made in the form of a cream or lotion so that it can be rubbed directly on the skin at the affected site.
  • the pharmaceutical composition for relieving the itch, pain, and swelling resulting from insect bites and stings disclosed herein may also contain an anesthetic and/or antibiotic.
  • a pharmaceutical composition containing an abrasive ingredient such as walnut shells. While satisfactory relief is obtained by applying a pharmaceutical composition containing 35-60 mesh walnut shells as an abrasive ingredient, the addition of polysorbate 60 and an itch- reducing enzyme papain to the overall pharmaceutical composition result in effective relief within a shorter time period from when the composition is rubbed on the area affected by the insect bite or sting.
  • the itch-reducing enzyme may be an ingredient selected from the group of subtilisin or pancreatin.
  • the preferred embodiment of the herein disclosed pharmaceutical composition contains the ingredients comprising polysorbate 60 and papain, together with the abrasive ingredient.
  • the abrasive ingredient is preferably meshed walnut shells. However, any abrasive material may be substituted therefore. It is believed that these ingredients operate effectively to draw the acids, mucoids, poisons, and similar debris from the site of the sting or bite. These acids, mucoids, poisons, and debris are then absorbed, neutralized and diluted in the composition while being simultaneously rubbed off from the affected body site.
  • the pharmaceutical composition also contains isopropyl palmitate and pentaerythrityl tetracapryate/caprate or other detersives as carriers and cleaning agents and to improve skin adhesion when in a wet state;
  • isopropyl palmitate and pentaerythrityl tetracapryate/caprate or other detersives as carriers and cleaning agents and to improve skin adhesion when in a wet state
  • the pharmaceutical composition also contains isopropyl palmitate and pentaerythrityl tetracapryate/caprate or other detersives as carriers and cleaning agents and to improve skin adhesion when in a wet state;
  • binders and emulsifiers such as poliwax emulsifying wax NF; the water soluble salts of cellulose ethers such as NaHCO 3 ; and finally, water as a solvent.
  • inert ingredients that may be used in this invention include: vegetable and fruit oils, soaps, surfactants, lubricants, mineral oils, petrolatum, gels lotions, emollients, white petroleum, beeswax, di-propylene glycol, gums, lubricating jelly and olive oils.
  • active ingredients include: menthol, Benadryl, diphenhydramine hydrochloride, germicidal disinfectants, aloe/aloe vera, silicone, antiseptic preparations, antimicrobial agents such as PCMX, broad spectrum surface disinfectants, lidocaine, boric acid/borates, vitamins, oils from flowers, plants or animals, Neosporin, hydrocortisone cream/acetate, swelling and pain reducers, benzocaine, isobutene, hydrogen peroxide, iodine, zinc acetate, ammonia hydroxide, citronella, peppermint oil, analgesic/antihistamine ingredients, calamine, camphor, clove oil and methylparaben.
  • the pharmaceutical composition be in the form of a cream or lotion for easy application and adhesion to the affected area, although a pharmaceutical composition in other forms, such as powder, could be used. If stored in powdered form, a small amount of water can be mixed with the powdered composition before use to improve the adhesive and abrasive qualities of the pharmaceutical composition.
  • the maximum concentration of the active ingredient is limited only by the desired form and consistency of the pharmaceutical composition. Active ingredient concentrations over those listed in the preferred embodiment may be used while still obtaining a satisfactory cream consistency.
  • the preferred concentration of the active ingredients from the standpoint of fast action, abrasive capacity, and cosmetic quality of the pharmaceutical composition as a cream, is between 20% and 60%. At low concentrations of the active ingredient the composition acts more slowly and has smaller abrasive capacity. The pharmaceutical composition appears to work well down to about 20% or less active ingredient concentration particularly for small bites or stings.
  • a preferred example of a formulation for the pharmaceutical composition disclosed herein, given in weight percentages, is:
  • a range of weight percentages for the formulation of the pharmaceutical composition disclosed herein is as follows:
  • All of the ingredients are preferably in the form of powder before mixing except glycerine and water.
  • abrasive anti-sting pharmaceutical composition of the present invention using the above listed ingredients is prepared according to the following steps:
  • the pharmaceutical composition having an abrasive action is now ready for application to the affected site for treating insect bites and stings.

Abstract

A pharmaceutical composition for relieving the itch, pain, and swelling resulting from insect bites and stings, and methods for producing and using the composition. The method preferably comprises topically applying to the affected area the composition which contains an abrasive ingredient and an anti-itch enzyme, both of which are dispersed in a carrier containing effective amounts of emulsifiers, and/or dispersants and may take the form of a powder, liquid, or paste. The final pharmaceutical composition is preferably made in the form of a cream or lotion sot that it can be rubbed directly on the skin at the affected site. The pharmaceutical composition for relieving the itch, pain, and swelling resulting from insect bites and stings disclosed herein may also contain an anesthetic and/or antibiotic.

Description

COMPOSITION COMPRISING AN ABRASIVE AGENT FOR TREATING INSECT BITES
Field and Background of the Invention
The present invention relates to non-prescription topical compositions and, more specifically, to a composition including an abrasive for treating effects such as itching, pain, and swelling resulting from insect bites and stings.
Description of the Prior Art
There are numerous preparations presently available to provide relief from the allergenic effects of insect bites and stings. For example, U.S. Patent Nos. 5,006,562; 4,678,668; 3,860,702; 3,825,664; 3,701,666; 3,697,287; 3,666,863; 3,515,749; 3,400,719; 3,324,002; 3,061,512; 2,917,433, 2,435,005, and 1,471,344 illustrate some such preparations. Most of these preparations are effective only to a degree and merely tend to anesthetize the site of the affected area. There is no prior art that describes a pharmaceutical composition that will draw the actual material causing the allergenic reaction from the site by way of an abrasive action, while simultaneously reducing the itch associated with insect bites and stings as in the present invention. While these units may be suitable for the particular purpose to which they address, they would not be as suitable for the purposes of the present invention as heretofore described.
Summary of the Invention
The present invention relates to non-prescription topical compositions and, more specifically, to a composition including an abrasive for treating effects such as itching, pain, and swelling resulting from insect bites and stings.
It is accordingly an object of the instant invention to provide a composition for topical application for the relief of allergenic reactions caused by insect bites and stings that overcomes the shortcomings of prior art preparations.
It is a further object of the present invention to provide a composition that is able to alleviate the discomfort associated with an insect bite or sting by way of an abrasive action.
It is a yet further object of the present invention to provide a composition that is able to alleviate the discomfort associated with an insect bite or sting which is able to reduce any itching associated with the insect bite or sting.
It is a still further object of the present invention to provide a composition that is able to alleviate the discomfort associated with an insect bite or sting which is able to soothe and moisturize the affected area.
It is another object of the present invention to provide a method for producing the composition at a relatively small cost thereby making it generally available. Another object of the present invention is to provide a composition and method for alleviating the discomfort associated with an insect bite or sting that is simple and easy to use.
A still further object of the present invention is to provide a composition that is able to alleviate the discomfort associated with an insect bite or sting that is economical in cost to manufacture.
These and other objects and advantages of the invention will become more apparent from the following detailed disclosure and claims.
Broadly speaking, the instant invention includes the provision of a topical skin preparation adapted to relieve the discomfort associated with insect bites comprising an effective amount of an abrasive ingredient (e.g. walnut shells), and an itch reducing ingredient (e.g. papain).
The present invention is directed to a method and pharmaceutical composition for reducing the itching associated with insect bites and stings. The method comprises applying a therapeutically effective amount of an abrasive ingredient and an itch reducing ingredient in a suitable pharmaceutical carrier to the surface of the skin proximate to the bite. The preferred abrasive ingredient is walnut shells and the preferred itch reducing ingredient is papain. However, any known abrasive and itch reducing ingredients may be used in the composition of the present invention. The pharmaceutical carrier may be water based.
Over the years, there have been reports of the utility of papain, commonly in the form of meat tenderizer, for the first aid treatment of hymenoptera stings. It has been suggested that a paste of the material can be applied topically and rubbed into the site of the sting, resulting in lessened swelling. The topical application of papain is effective in reducing the itch associated with insect bites. According to the invention, a method of relieving the allergenic effects of insect stings and bites, comprises topically rubbing a pharmaceutical composition containing, among other materials, an abrasive ingredient, such as walnut shells (35-60 mesh) on the affected area.
A pharmaceutical composition for topical use in accordance with the method comprises an active abrasive ingredient, as indicated above, in a carrier suitable for topical application to the human skin, for example, in a mixture of propylene glycol and water.
The topical pharmaceutical carrier may include any substance capable of dispersing and maintaining contact between the active abrasive and anti-itch ingredients and the skin. The vehicle may be glycerin, alcohol or water based. Examples of such vehicles include aloe vera, which is a gel base, together with ethanol, isopropyl alcohol, water, and propylene glycol. Other water-based alcohol/glycerin vehicles and carriers are within the scope of the present invention.
It has been found that a pharmaceutical composition containing an abrasive ingredient works very well to alleviate the allergenic effects of insect stings and bites. Although, in the preferred embodiment disclosed herein, walnut shells (35-60 mesh), work effectively, other similarly sized abrasive materials can be used in the overall pharmaceutical composition including but not limited to any of the following: pumice, plastic materials, sand or stone, glass, seed or fruit shells, seeds, metal, any sort of brush, abrasive applicators, chitosan or ground crab shells. The remainder of the pharmaceutical composition may comprise carriers, emulsifiers, and/or dispersants and may take the form of a powder, liquid, or paste. The final pharmaceutical composition is preferably made in the form of a cream or lotion so that it can be rubbed directly on the skin at the affected site. When the instant cream or lotion is rubbed on the bite or sting affected area, it appears that the active abrasive ingredients actually draw the allergenic or poisonous substance from the affected area along with any body materials resulting from swelling or infection.
A mild anesthetic, such as menthol, chloroform, benzocaine or an antibiotic may be added to the overall claimed abrasive pharmaceutical composition in a manner well known in the art.
A pharmaceutical composition for relieving the itch, pain, and swelling resulting from insect bites and stings, and methods for producing and using the composition is disclosed by the present invention. The method preferably comprises topically applying to the affected area the composition containing an abrasive ingredient and an anti-itch enzyme, both of which are dispersed in a carrier containing effective amounts of emulsifiers, and/or dispersants and may take the form of a powder, liquid, or paste. The final pharmaceutical composition is preferably made in the form of a cream or lotion so that it can be rubbed directly on the skin at the affected site. The pharmaceutical composition for relieving the itch, pain, and swelling resulting from insect bites and stings disclosed herein may also contain an anesthetic and/or antibiotic.
To the accomplishment of the above and related objects, this invention may be embodied in the form illustrated in the accompanying drawings, attention being called to the fact, however, that the drawings are illustrative only, and that changes may be made in the specific construction illustrated and described within the scope of the appended claims. Detailed Description of a Preferred Embodiment
It has been found that very effective relief from the allergenic effects of insect bites and stings may be had by topically applying to the affected area a pharmaceutical composition containing an abrasive ingredient such as walnut shells. While satisfactory relief is obtained by applying a pharmaceutical composition containing 35-60 mesh walnut shells as an abrasive ingredient, the addition of polysorbate 60 and an itch- reducing enzyme papain to the overall pharmaceutical composition result in effective relief within a shorter time period from when the composition is rubbed on the area affected by the insect bite or sting. In place of papain, the itch-reducing enzyme may be an ingredient selected from the group of subtilisin or pancreatin. Not only is the itching relieved by way of the enzyme papain, subtilisin or pancreatin, but any attendant swelling that has occurred is also removed by way of the abrasive action of the walnut shells, and further swelling, itching or other allergenic effects are thus prevented.
The preferred embodiment of the herein disclosed pharmaceutical composition contains the ingredients comprising polysorbate 60 and papain, together with the abrasive ingredient. The abrasive ingredient is preferably meshed walnut shells. However, any abrasive material may be substituted therefore. It is believed that these ingredients operate effectively to draw the acids, mucoids, poisons, and similar debris from the site of the sting or bite. These acids, mucoids, poisons, and debris are then absorbed, neutralized and diluted in the composition while being simultaneously rubbed off from the affected body site.
In addition to the above listed ingredients, it is preferred that the pharmaceutical composition also contains isopropyl palmitate and pentaerythrityl tetracapryate/caprate or other detersives as carriers and cleaning agents and to improve skin adhesion when in a wet state; catrearyl alcohol, propylene glycol, ethyl alcohol or other polyhydric alcohols to avoid drying; binders and emulsifiers such as poliwax emulsifying wax NF; the water soluble salts of cellulose ethers such as NaHCO3; and finally, water as a solvent.
Other inert ingredients that may be used in this invention include: vegetable and fruit oils, soaps, surfactants, lubricants, mineral oils, petrolatum, gels lotions, emollients, white petroleum, beeswax, di-propylene glycol, gums, lubricating jelly and olive oils. Other active ingredients that may be used in this invention include: menthol, Benadryl, diphenhydramine hydrochloride, germicidal disinfectants, aloe/aloe vera, silicone, antiseptic preparations, antimicrobial agents such as PCMX, broad spectrum surface disinfectants, lidocaine, boric acid/borates, vitamins, oils from flowers, plants or animals, Neosporin, hydrocortisone cream/acetate, swelling and pain reducers, benzocaine, isobutene, hydrogen peroxide, iodine, zinc acetate, ammonia hydroxide, citronella, peppermint oil, analgesic/antihistamine ingredients, calamine, camphor, clove oil and methylparaben. It is preferred that the pharmaceutical composition be in the form of a cream or lotion for easy application and adhesion to the affected area, although a pharmaceutical composition in other forms, such as powder, could be used. If stored in powdered form, a small amount of water can be mixed with the powdered composition before use to improve the adhesive and abrasive qualities of the pharmaceutical composition.
The maximum concentration of the active ingredient is limited only by the desired form and consistency of the pharmaceutical composition. Active ingredient concentrations over those listed in the preferred embodiment may be used while still obtaining a satisfactory cream consistency. The preferred concentration of the active ingredients from the standpoint of fast action, abrasive capacity, and cosmetic quality of the pharmaceutical composition as a cream, is between 20% and 60%. At low concentrations of the active ingredient the composition acts more slowly and has smaller abrasive capacity. The pharmaceutical composition appears to work well down to about 20% or less active ingredient concentration particularly for small bites or stings.
A preferred example of a formulation for the pharmaceutical composition disclosed herein, given in weight percentages, is:
Walnut Shells (30-60mesh) 15.00%
Papain 00.10%
Polysorbate 60 03.00%
Isopropyl Palmitate 03.50%
Pentaerythrityl 03.50%
Tetracapryate/caprate
Poliwax emulsifying 04.00% wax NF
Cetrearyl alcohol 03.00%
Ethyl alcohol 00.10%
Sodium Hydroxide qs pH=8.50
NaHC03 02.00%
Propylene Glycol 04.00%
Water (distilled) 61.08%
A range of weight percentages for the formulation of the pharmaceutical composition disclosed herein is as follows:
Walnut Shells (30-60mesh) 5.00-25.00%
Papain .01-1.00%
Polysorbate 60 1.00-6.00%
Isopropyl Palmitate 1.00-6.00%
Pentaerythrityl 1.00-6.00%
Tetracapryate/caprate Poliwax emulsifying 2.00-8.00% wax NF
Cetrearyl alcohol 2.00-7.00%
Ethyl alcohol 0.10-5.00%
Sodium Hydroxide qs pH=8.50
NaHC03 0.50-5.00%
Propylene Glycol 1.00-6.00%
Water (distilled) remainder of composition
All of the ingredients are preferably in the form of powder before mixing except glycerine and water.
The abrasive anti-sting pharmaceutical composition of the present invention using the above listed ingredients is prepared according to the following steps:
1) Add the water and the propylene glycol to a first vessel and heat to 75 degrees Celsius with stirring;
2) Add to a second vessel the Polysorbate 60, Isopropyl Palmitate, Pentaerythrityl Tetracapryate/caprate, Poliwax emulsifying wax NF, Cetrearyl alcohol, and heat to 75 degrees Celsius with some stirring until homogeneous;
3) With rapid mixing, add the contents of the second vessel slowly to the first vessel and add Ethyl alcohol;
4) Remove the combined mixture in vessel 1 from the heat and start cooling;
5) At 50 degrees Celsius stir in the meshed walnut shells, NaCHO3 and the papain: 6) Adjust the PH to 7.50 and stir in the Sodium Hydroxide;
7) Check the pH again and adjust if necessary.
The pharmaceutical composition having an abrasive action is now ready for application to the affected site for treating insect bites and stings.
In actual use to treat insect stings and bites, when the pharmaceutical composition is applied to the site soon after the sting or bite occurs, effective relief is had in a matter of seconds. In instances of severe allergenic effects or reactions to insect bites and stings, it is important to apply the pharmaceutical composition immediately after the sting or bite is received so that the allergenic material can be withdrawn rapidly from the body before getting into the bloodstream.
Whereas the invention has been described herein with reference to the presently preferred pharmaceutical composition listed above, it should be understood that various changes may be made by one skilled in the art without departing from the disclosed inventive concepts particularly pointed out above and as claimed by me hereinafter.
It will be understood that each of the elements described above, or two or more together may also find a useful application in other types of methods differing from the type described above.
While certain novel features of this invention have been shown and described and are pointed out in the annexed claims, it is not intended to be limited to the details above, since it will be understood that various omissions, modifications, substitutions and changes in the forms and details of the device illustrated and in its operation can be made by those skilled in the art without departing in any way from the spirit of the present invention. Without further analysis, the foregoing will so fully reveal the gist of the present invention that others can, by applying current knowledge, readily adapt it for various applications without omitting features that, from the standpoint of prior art, fairly constitute essential characteristics of the generic or specific aspects of this invention.

Claims

ClaimsI claim:
1. A method of relieving an itch, pain, and swelling resulting from insect bites and stings, said method comprising the step of topically applying to the affected area a pharmaceutical composition containing an effective amount of an abrasive ingredient, together with a carrier material for said abrasive ingredient.
2. The method according to claim 1, wherein the abrasive ingredient is selected from the group consisting of walnut shells, pumice, plastic materials, sand or stone, glass, seed or fruit shells, seeds, metal, any sort of brush, abrasive applicators, chitosan or ground crab shells, all at 35-60 mesh.
3. The method according to claim 2, wherein said abrasive ingredient is applied as a solution in an aqueous pharmaceutical carrier.
4. A pharmaceutical composition for topical application to the site of insect bites and stings to relieve the itch, pain, and swelling associated therewith, comprising an effective amount of an abrasive ingredient selected from the group thereof consisting of walnut shells pumice, plastic materials, sand or stone, glass, seed or fruit shells, seeds, metal, any sort of brush, abrasive applicators, chitosan or ground crab shells, all at 35-60 mesh, and a carrier for said active ingredient suitable for topical application to the human skin, said carrier selected from the group consisting of vegetable and fruit oils, soaps, surfactants, lubricants, mineral oils, petrolatum, gels lotions, emollients, white petroleum, beeswax, di-propylene glycol, gums, lubricating jelly and olive oils.
5. The pharmaceutical composition for topical application according to claim 4, wherein an itch-reducing amount of an enzyme chosen from the group consisting of papain, subtilisin, and pancreatin, is added to the pharmaceutical composition for application to the surface of the skin proximate to said insect bite or sting.
6. The pharmaceutical composition for topical application according to claim 4,wherein the composition is in the form of a lotion.
7. The pharmaceutical composition for topical application according to claim 4, wherein the composition is in the form of a paste.
8. The pharmaceutical composition for topical application according to claim 4, wherein the composition is in the form of a liquid.
9. The pharmaceutical composition for topical application according to claim 4, wherein the composition is in the form of a powder.
10. The pharmaceutical composition for topical application according to claim 4, wherein the composition additionally includes an anesthetic.
11. The pharmaceutical composition for topical application according to claim 10 wherein the anesthetic is selected from the group consisting of menthol, Benadryl, diphenhydramine hydrochloride, germicidal disinfectants, aloe/aloe vera, silicone, antiseptic preparations, antimicrobial agents such as PCMX, broad spectrum surface disinfectants, lidocaine, boric acid/borates, vitamins, oils from flowers, plants or animals, Neosporin, hydrocortisone cream/acetate, swelling and pain reducers, benzocaine, isobutene, hydrogen peroxide, iodine, zinc acetate, ammonia hydroxide, citronella, peppermint oil, analgesic/antihistamine ingredients, calamine, camphor, clove oil and methylparaben.
12. The pharmaceutical composition according to claim 5 wherein said abrasive ingredient and said anti-itch enzyme are applied as a solution in an aqueous pharmaceutical carrier.
13. The pharmaceutical composition for topical application to the site of insect bites and stings to relieve the itch, pain, and swelling associated therewith, comprising an effective amount of an abrasive ingredient; and effective amount of an anti-itch enzyme; said abrasive ingredient and said anti-itch enzyme being dispersed in a water based pharmaceutical carrier comprising effective amounts of polysorbate 60; isopropyl palmitate; pentaerythrityl tetracapryate/caprate; poliwax emulsifying wax NF; cetrearyl alcohol; ethyl alcohol; sodium hydroxide; NaHCO3; and propylene glycol.
14. The pharmaceutical composition for topical application according to claim 13,wherein the composition is in the form of a lotion.
15. The pharmaceutical composition for topical application according to claim 13, wherein the composition is in the form of a paste.
16. The pharmaceutical composition for topical application according to claim 13, wherein the composition is in the form of a liquid.
17. The pharmaceutical composition for topical application according to claim 13, wherein the composition is in the form of a powder.
18. The pharmaceutical composition for topical application according to claim 13, wherein the composition additionally includes an anesthetic.
19. The pharmaceutical composition for topical application according to claim 18, wherein the anesthetic is selected from the group consisting of menthol, Benadryl, diphenhydramine hydrochloride, germicidal disinfectants, aloe/aloe vera, silicone, antiseptic preparations, antimicrobial agents such as PCMX, broad spectrum surface disinfectants, lidocaine, boric acid/borates, vitamins, oils from flowers, plants or animals, Neosporin, hydrocortisone cream/acetate, swelling and pain reducers, benzocaine, isobutene, hydrogen peroxide, iodine, zinc acetate, ammonia hydroxide, citronella, peppermint oil, analgesic/antihistamine ingredients, calamine, camphor, clove oil and methylparaben.
20. A method of producing the pharmaceutical composition for topical application according to claim 13, comprising the steps of: adding distilled water and propylene glycol to a first vessel; heating the first vessel to 75 degrees Celsius with stirring; adding to a second vessel, effective amounts of polysorbate 60, isopropyl palmitate, pentaerythrityl tetracapryate/caprate, poliwax emulsifying wax NF, and cetrearyl alcohol; heating the second vessel to 75 degrees Celsius with some stirring until homogeneous; adding the contents of the second vessel slowly to the first vessel, with rapid mixing; adding an Ethyl alcohol to the combined mixture in vessel 1 ; removing the combined mixture in vessel 1 from the heat and start cooling said vessel; stirring in an abrasive ingredient and NAHCO3 and anti-itch enzyme at 50 degrees Celsius; adjusting the PH to 7.50; stirring in the Sodium Hydroxide; and checking the pH is again and adjusting if necessary.
21. A pharmaceutical composition for topical application to the site of insect bites and stings to relieve the itch, pain, and swelling associated therewith, comprising an effective amount of an abrasive ingredient and a carrier for said active ingredient suitable for topical application to the human skin.
21. The composition according to Claim 21 , wherein the abrasive ingredient is selected from the group thereof consisting of walnut shells pumice, plastic materials, sand or stone, glass, seed or fruit shells, seeds, metal, any sort of brush, abrasive applicators, chitosan or ground crab shells.
22. The composition according to Claim 22, wherein the abrasive ingredient is at 35-60 mesh.
23. The composition according to Claim 21 , wherein the carrier is said carrier selected from the group consisting of vegetable and fruit oils, soaps, surfactants, lubricants, mineral oils, petrolatum, gels lotions, emollients, white petroleum, beeswax, di-propylene glycol, gums, lubricating jelly and olive oils.
24. The composition according to Claim 21 , wherein an itch-reducing amount of an enzyme chosen from the group consisting of papain, subtilisin, and pancreatin, is added to the pharmaceutical composition for application to the surface of the skin proximate to said insect bite or sting.
25. The pharmaceutical composition for topical application according to claim 21,wherein the composition is in the form of a lotion.
26. The pharmaceutical composition for topical application according to claim 21, wherein the composition is in the form of a paste.
27. The pharmaceutical composition for topical application according to claim 21, wherein the composition is in the form of a liquid.
28. The pharmaceutical composition for topical application according to claim 21, wherein the composition is in the form of a powder.
29. The pharmaceutical composition for topical application according to claim 21, wherein the composition additionally includes an anesthetic.
30. The pharmaceutical composition for topical application according to claim 29, wherein the anesthetic is selected from the group consisting of menthol, Benadryl, diphenhydramine hydrochloride, germicidal disinfectants, aloe/aloe vera, silicone, antiseptic preparations, antimicrobial agents such as PCMX, broad spectrum surface disinfectants, lidocaine, boric acid/borates, vitamins, oils from flowers, plants or animals, Neosporin, hydrocortisone cream/acetate, swelling and pain reducers, benzocaine, isobutene, hydrogen peroxide, iodine, zinc acetate, ammonia hydroxide, citronella, peppermint oil, analgesic/antihistamine ingredients, calamine, camphor, clove oil and methylparaben.
31. The pharmaceutical composition according to claim 22 wherein said abrasive ingredient and said anti-itch enzyme are applied as a solution in an aqueous pharmaceutical carrier.
PCT/US2002/030244 2002-09-11 2002-09-11 Composition comprising an abrasive agent for treating insect bites WO2004024169A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU2002332213A AU2002332213A1 (en) 2002-09-11 2002-09-11 Composition comprising an abrasive agent for treating insect bites
PCT/US2002/030244 WO2004024169A1 (en) 2002-09-11 2002-09-11 Composition comprising an abrasive agent for treating insect bites

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2002/030244 WO2004024169A1 (en) 2002-09-11 2002-09-11 Composition comprising an abrasive agent for treating insect bites

Publications (1)

Publication Number Publication Date
WO2004024169A1 true WO2004024169A1 (en) 2004-03-25

Family

ID=31989887

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/030244 WO2004024169A1 (en) 2002-09-11 2002-09-11 Composition comprising an abrasive agent for treating insect bites

Country Status (2)

Country Link
AU (1) AU2002332213A1 (en)
WO (1) WO2004024169A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1878433A1 (en) * 2006-07-14 2008-01-16 Paolo Colombini Topical composition comprising magmatites
GB2485834A (en) * 2010-11-29 2012-05-30 Barry Sonenfeld Composition comprising emulsifying ointment and water
CN107823174A (en) * 2017-12-04 2018-03-23 安徽金太阳生化药业有限公司 A kind of preparation method of pancreatic enzymes enteric coated capsule

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3383280A (en) * 1963-01-09 1968-05-14 Miles Lab Dermatological abradant stick-type applicator
US4083965A (en) * 1975-01-16 1978-04-11 Bluhm Henry P Method of and composition for relieving itch, pain and swelling resulting from insect stings and bites and skin contact with noxious plants
US5543149A (en) * 1995-03-01 1996-08-06 Rubin; Stan M. Treatment for insect bites
WO2000038778A1 (en) * 1998-12-29 2000-07-06 John Brian Mcadams A method and article for debridement and detoxification of wounds
US6325783B1 (en) * 1998-01-20 2001-12-04 Laughlin Products, Inc. Process for bleaching chemically tanned skin and discolored nails
US6423343B1 (en) * 1998-01-23 2002-07-23 Usbiomaterials Corporation Bioactive glass treatment of inflammation in skin conditions
US6432430B1 (en) * 2000-11-17 2002-08-13 Edwin Fitzjarrell Exfoliating scrub with niacinamide
US20020192304A1 (en) * 2001-04-30 2002-12-19 Patrick Kennedy Pharmaceutical composition and method for relieving itch, pain and swelling resulting from insect bites and stings

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3383280A (en) * 1963-01-09 1968-05-14 Miles Lab Dermatological abradant stick-type applicator
US4083965A (en) * 1975-01-16 1978-04-11 Bluhm Henry P Method of and composition for relieving itch, pain and swelling resulting from insect stings and bites and skin contact with noxious plants
US5543149A (en) * 1995-03-01 1996-08-06 Rubin; Stan M. Treatment for insect bites
US6325783B1 (en) * 1998-01-20 2001-12-04 Laughlin Products, Inc. Process for bleaching chemically tanned skin and discolored nails
US6423343B1 (en) * 1998-01-23 2002-07-23 Usbiomaterials Corporation Bioactive glass treatment of inflammation in skin conditions
WO2000038778A1 (en) * 1998-12-29 2000-07-06 John Brian Mcadams A method and article for debridement and detoxification of wounds
US6432430B1 (en) * 2000-11-17 2002-08-13 Edwin Fitzjarrell Exfoliating scrub with niacinamide
US20020192304A1 (en) * 2001-04-30 2002-12-19 Patrick Kennedy Pharmaceutical composition and method for relieving itch, pain and swelling resulting from insect bites and stings

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1878433A1 (en) * 2006-07-14 2008-01-16 Paolo Colombini Topical composition comprising magmatites
GB2485834A (en) * 2010-11-29 2012-05-30 Barry Sonenfeld Composition comprising emulsifying ointment and water
CN107823174A (en) * 2017-12-04 2018-03-23 安徽金太阳生化药业有限公司 A kind of preparation method of pancreatic enzymes enteric coated capsule

Also Published As

Publication number Publication date
AU2002332213A1 (en) 2004-04-30

Similar Documents

Publication Publication Date Title
KR101420599B1 (en) Compositions containing anti-acne agents and the use thereof
CA2567575C (en) Organo-gel formulations for therapeutic applications
JP3211027B2 (en) Topical containing capsaicin
US9084821B2 (en) Transdermal compositions
US7166281B2 (en) Pharmaceutical composition and method for relieving itch, pain and swelling resulting from insect bites and stings
EP0481007B1 (en) SLOW RELEASE VEHICLES FOR MINIMIZING SKIN IRRITANCY OF TOPICAL COMPOSITIONS containing retinoids
JP5198846B2 (en) Methods and compositions for burned skin
IL180691A (en) Organo-gel formulations for therapeutic applications
EP2319510A1 (en) Benzoyl peroxide composition for treating skin
CN108186679B (en) Acne removing composition
JP2012526727A (en) Composition suitable for topical treatment of fungal infections of the skin and nails
WO2011119247A2 (en) Topical skincare composition
CN111836614A (en) Topical skin care compositions
US20080076831A1 (en) Hemorrhoid reliever and method of use
US20050123576A1 (en) Mupirocin compositions for topical use, an improved process of making same and methods of using same
EP2200582B1 (en) Use of carriers as preservatives and pharmaceutical composition containing same
US20140348873A1 (en) Urea-Silicone Gel for Hyperkeratosis Treatment
US5435997A (en) Topical agent and method for the treatment of pseudofolliculitis barbae
WO2004024169A1 (en) Composition comprising an abrasive agent for treating insect bites
CN113347982A (en) Dermal skin protectant and carrier
FR3025106A1 (en) ANTIMICROBIAL COMPOSITION
US20040072789A1 (en) Veterinary composition for the topical treatment of traumatized or inflamed skin
US20080193552A1 (en) Topical medicament for skin injuries and disorders
US9011934B2 (en) Multi-purpose anti-itch treatment
FR2566270A1 (en) Pharmaceutical dosage forms in gel form, for the topical application of active principles

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established
32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP